Seikagaku Kogyo Co. Ltd.

General Electric Company

Seikagaku Kogyo Kabushiki Kaisha (seikagaku Corporation)

Nippon Steel Chemical & Material Co., Ltd.

Yuko Shibata

Shigenori Tanaka

Jun Aketagawa

Hiroshi Tamura

Shoji Takahashi

Makoto Ohki

Hiroshi Sato

Tomoyuki Suzuki

Seiji Funaya

Yuri Teraoka

Manabu Arima

Masaru Ogasawara

An object is to provide an epoxy resin composition which exhibits excellent tracking resistance and additionally has excellent heat resistance with a Tg of 200&#xb0; C. or higher and flame retardancy. Provided is an epoxy resin composition which contains a phosphorus-containing epoxy resin and a curing agent and has a phosphorus content of within a range of 1.0 to 1.8%, wherein the phosphorus-containing epoxy resin has a ratio (L/H) of 0.6 to 4.0 of the content of trinuclear bodies (L) to the content of hepta or higher nuclear bodies (H) measured by GPC, and is a product obtained from a novolac epoxy resin having an average number of functional groups (Mn/E) of 3.8 to 4.8 and a phosphorus compound represented by the following general formula (1) and/or general formula (2).

Phosphorus-containing epoxy resin, epoxy resin composition, prepreg, laminated plate, material for circuit board and cured product

[Problem] To provide an ultrasonic apparatus that enables one to find a factor that lowers reliability of a measurement value relating to elasticity of biological tissue. [Means for Solution] An ultrasonic diagnostic apparatus comprises a control circuit executing: a measurement-value calculating functionof calculating a measurement value relating to elasticity of the biological tissue based on echo signals from ultrasonic detecting pulses; an index-value calculating functionof calculating an index value indicating a degree of reliability for the measurement value for each of a plurality of factors that deteriorate the reliability of the measurement value based on the echo signals from the ultrasonic detecting pulses; and a notifying function of notifying a factor corresponding to at least one index value for which the degree of reliability does not meet a required standard.

Ultrasonic apparatus, and program for controlling the same

A systemcomprises a first medical image capture apparatus ULand a second medical image capture apparatus ULthat share values of at least some of a plurality of preferences and are of different kinds, wherein a first control devicein the first ultrasonic diagnostic apparatus ULexecutes an output function of outputting a value of a preference that the first input devicehas accepted, to a serveralong with information on the kind of the first ultrasonic diagnostic apparatus UL, and a server control deviceconverts the output value of the preference based on conversion information, and then, transmits the converted value to the second ultrasonic diagnostic apparatus UL. The second ultrasonic diagnostic apparatus ULconverts the converted value from the serverinto that in the kind of the second medical image capture apparatus, and performs setting of the converted value.

Ultrasound diagnostic system

This invention relates to a horseshoe crab amebocyte lysate factor G activation inhibitor comprising as an active ingredient a polyglycoside containing at least one poly-(1.fwdarw.3)-.beta.-D-glucoside structure portion consisting of 2 to 370 (1.fwdarw.3)-.beta.-D-glucoside structural units of the following formula ##STR1## which are continuously bound to one another. This inhibitor is useful for inhibiting the activation of factor G which may exist in horseshoe crab amebocyte lysate used in the Limulus test.

Horseshoe crab amebocyte lysate factor G activation inhibitor

The invention stabilizes single helix conformation (1.fwdarw.3)-.beta.-D-glucans by intramolecular crosslinking and provides (1.fwdarw.3)-.beta.-D-glucans showing stable biological activities. Thus, intramolecularly crosslinked (1.fwdarw.3)-.beta.-D-glucans having a stable single helix conformation are produced by introducing a functional group into hydroxyl groups of (1.fwdarw.3)-.beta.-D-glucans, then causing the thus-obtained functional glucans to take a single helix conformation, and subjecting these, either as such or after binding them to a receptor therefor, to intramolecular crosslinking between the functional groups introduced, if necessary followed by releasing the receptor therefrom.

Intramolecularly crosslinked (1.fwdarw.3)-.beta.-D-glucans

Method of preparing Limulus amoebocyte lysate

Growing community of inventors

Tokyo, Japan

Yuko Shibata